Navigation Links
China Medicine to Showcase 'Bethin' Weight Loss Product at 2008 Natural Products Expo East Trade Show

GUANGZHOU, China, Oct. 13 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary supplements, medical devices, and medical formulations in the People's Republic of China ("PRC"), through its wholly-owned U.S subsidiary, Konzern U.S Holding Corporation, announced today that it will participate in the 2008 Natural Products Expo East tradeshow, where it will showcase its new weight loss product called "Bethin." The tradeshow will be held Oct. 15th to Oct. 18th at the Boston Convention & Exhibition Center in Massachusetts. Over 25,000 natural, organic, and health products industry members will participate in this event.

China Medicine's proprietary weight loss product, Bethin, is a food supplement that is designed to promote and adjust fat metabolism, reduce the storage of fat in the body, and prolong endurance during physical exercise. Bethin's active ingredients include L-Carnitine, a special amino acid manufactured by the human body that is essential for the production of energy, and Hydroxycitric acid (HCA), an extract from the fruit of the Garcinia cambogia plant. The Company has filed and obtained all the necessary documentation to launch the new product in the United States.

"We are looking forward to taking part in the upcoming Natural Products Expo East tradeshow in Boston," said Mr. Senshan Yang, Chairman and CEO of China Medicine. "We anticipate that the introduction of Bethin, our first product sold in U. S. market, will increase our visibility, highlight the benefits of our new product, and allow us to gain a foothold in the international market."

The Company will be exhibiting its product in booth #240. For more information on the tradeshow, please click .

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements. The Company distributes the products to wholesale distributors in 28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feed. For more information visit the Company's website at .

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risk factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

For further information, please contact:

China Medicine Corp

Ms. Huizhen Yu


Tel: +86-20-8739-1718


Mr. Crocker Coulson


CCG InvestorRelations Inc.

Tel: +1-646-213-1915


SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
2. China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
3. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
4. Covance Decides to Pursue Its Original Preclinical Strategy in China
5. China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
6. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
7. Chinas Farmers Welcome the New Trend of Organic Farming
8. China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification
9. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
10. China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
11. China Biopharma Effects 1 for 100 Reverse Stock Split
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):